Brief: Swedish Orphan Biovitrum Targets SEK 55 Billion Revenue By 2030
Feb 18 (Reuters) - Swedish Orphan Biovitrum AB (publ) SOBIV.ST: SOBI TARGETS EBITA MARGIN IN UPPER 30S BY 2030 SOBI TARGETS SEK 55BN REVENUE BY 2030 SOBI RESEARCH AND DEVELOPMENT EXPENSES TO REMAIN 11-14% OF SALES UNTIL 2030 Source text: ID:nWkr9kbK4M Further company coverage: SOBIV.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Swedish Orphan Biovitrum AB (publ)
See all newsTop of the Street: SOBI, Sonova, BAT, Imperial Brands
SOBI slips after Ionis lowers Tryngolza sales forecast
Brief: Swedish Orphan Biovitrum Executive Sells, Buys Shares
Europe Research Roundup: Centrica, Fuchs, URW
Brief: Swedish Orphan Biovitrum Proposes Börje Ekholm As New Chair And Board Member At 2027 AGM